BridgeBio Oncology Therapeutics Funding: $200M Raised

BridgeBio Oncology Therapeutics funding overview

BridgeBio Oncology Therapeutics is based in Palo Alto, California. BridgeBio Oncology Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in May 2024. The round record for BridgeBio Oncology Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Cormorant Asset Management, Omega Funds, Deerfield Management, GV (Google Ventures), EcoR1 Capital, Wellington Management and 5 others. 11 distinct backers are named across the disclosed rounds.

BridgeBio Oncology Therapeutics at a glance

Total raised

$200M

Latest round

Growth

Latest round date

May 2024

Headquarters

Palo Alto, California

Notable investors

Cormorant Asset Management, Omega Funds, Deerfield Management, GV (Google Ventures), EcoR1 Capital, Wellington Management, Enavate Sciences, Surveyor Capital (a Citadel company)

Frequently asked about BridgeBio Oncology Therapeutics funding

How much has BridgeBio Oncology Therapeutics raised?

BridgeBio Oncology Therapeutics has raised $200M in total disclosed funding across the rounds on record.

Who has invested in BridgeBio Oncology Therapeutics?

Cormorant Asset Management, Omega Funds, Deerfield Management, GV (Google Ventures), EcoR1 Capital, Wellington Management are named among the investors backing BridgeBio Oncology Therapeutics.

What was the latest BridgeBio Oncology Therapeutics funding round?

The most recent disclosed round is a Growth, announced in May 2024.

Where is BridgeBio Oncology Therapeutics based?

BridgeBio Oncology Therapeutics is based in Palo Alto, California.

When did BridgeBio Oncology Therapeutics last raise?

The last disclosed BridgeBio Oncology Therapeutics round closed in May 2024 at Growth.

Totals shown for BridgeBio Oncology Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Palo Alto and the investors behind them below.

Companies related to BridgeBio Oncology Therapeutics (36)

• Autolus
• Spyre Therapeutics
• Alumis
• Edgewise Therapeutics
• Talaris Therapeutics
• Axon Neurosciences
• Aspen Neuroscience
• Viela Bio
• Greenlight Biosciences
• Triveni Bio
• NiKang Therapeutics
• Enliven Therapeutics
• Supira Medical
• Aligos Therapeutics
• OnKure Therapeutics
• EpimAb Biotherapeutics
• Verve Therapeutics
• VelosBio
• TripActions
• PsiQuantum
• Inflection AI
• Lambda
• SambaNova Systems
• World Labs
• BridgeBio Pharma
• Aeva
• Plume Design
• Ultima Genomics
• Next Insurance
• Houzz
• Medable
• Drip Capital
• Decart
• Rhoda AI
• Wisk Aero
• MainFunc

Browse related funding lists (11)

• Growth stage companies
• Startups in Palo Alto
• Investors in Palo Alto
• Companies that raised 100m 500m
• Companies funded in 2024
• Companies backed by Cormorant Asset Management
• Companies backed by Deerfield Management
• Companies backed by EcoR1 Capital
• Companies backed by GV (Google Ventures)
• Companies backed by Omega Funds
• Companies backed by Wellington Management

Company funding database · Investor directory · Founder database · Mega-rounds 2026